Tweenvest Stocks

Translational Development Acquisition Corp. (NasdaqGM: TDAC)

Financials · Capital Markets · US

$10.82

-0.37% today · +5.3% 1Y

Translational Development Acquisition Corp. (NasdaqGM: TDAC) operates in the Capital Markets industry within the Financials sector. The company is valued at $275.38M and employs 2 people.

Over the last twelve months the share price has gained 5.3%, trading between 10.32 and 10.95.

Tweenvest scores Translational Development Acquisition Corp. across four factors: quality 8/100. Its strongest factor is quality.

TDAC price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$275.38M
Revenue (TTM)
P/E
EPS
0.28
Dividend yield
Beta (5Y)
52-week high
$10.95
52-week low
$10.32
Avg volume (3M)
Shares outstanding
21.91M
Employees
2
Next earnings

About Translational Development Acquisition Corp.

Translational Development Acquisition Corp., founded in 2022 and headquartered in New York, New York, currently conducts no significant business operations. Its primary goal is to complete a business combination, such as a merger, amalgamation, share exchange, asset acquisition, share purchase, or reorganization, with one or more companies.

ISIN
KYG9008W1050
Founded
2022
Listed since
Feb 20, 2025
Exchange
Nasdaq Global Market
Currency
USD
CompanyMarket capPriceDay
Vanguard Index Funds - Vanguard Morningstar Total Stock Market ETFARCA: VTI$2.31T$378.15+0.29%
Vanguard Index Funds - Vanguard S&P 500 ETFARCA: VOO$1.67T$704.02+0.31%
iShares Trust - iShares Core S&P 500 ETFARCA: IVV$892.30B$769.62+0.32%
State Street SPDR S&P 500 ETF TrustARCA: SPY$811.28B$765.91+0.32%
Invesco QQQ Trust, Series 1NasdaqGM: QQQ$483.79B$710.72+0.62%
Vanguard Index Funds - Vanguard Morningstar Growth ETFARCA: VUG$378.70B$87.40+0.54%
Morgan StanleyNYSE: MS$340.45B$213.46-1.53%
The Goldman Sachs Group, Inc.NYSE: GS$320.59B$1,041.94-1.60%

Browse every Capital Markets company →

Figures last refreshed Aug 18, 2026.